198 related articles for article (PubMed ID: 20146029)
1. Guidelines for safety management of granulocyte transfusion in Japan.
Ohsaka A; Kikuta A; Ohto H; Ohara A; Ishida A; Osada K; Tasaki T; Kamitamari A; Iwai A; Kai S; Maekawa T; Hoshi Y;
Int J Hematol; 2010 Mar; 91(2):201-8. PubMed ID: 20146029
[TBL] [Abstract][Full Text] [Related]
2. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis.
Grigull L; Pulver N; Goudeva L; Sykora KW; Linderkamp C; Beilken A; Seidemann K; Schmid H; Welte K; Heuft HG
Support Care Cancer; 2006 Sep; 14(9):910-6. PubMed ID: 16622651
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte transfusions in the G-CSF era. Where do we stand?
Robinson SP; Marks DI
Bone Marrow Transplant; 2004 Nov; 34(10):839-46. PubMed ID: 15273712
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic transfusions of granulocytes collected by simple bag method for children with cancer and neutropenic infections: results of a single-centre pilot study.
Kikuta A; Ohto H; Nemoto K; Mochizuki K; Sano H; Ito M; Suzuki H
Vox Sang; 2006 Jul; 91(1):70-6. PubMed ID: 16756604
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience.
Pham HP; Rogoza K; Stotler B; Duffy D; Parker-Jones S; Ginzburg Y; Bhatia M; Cairo M; Schwartz J
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e332-6. PubMed ID: 22858567
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hematologic parameters of donors, patients, and granulocyte concentrates to predict successful granulocyte transfusion.
Lee JM; Choi SJ; Kim HS; Yang M; Kim Y; Lee JW; Lim J
Blood Res; 2019 Mar; 54(1):52-56. PubMed ID: 30956964
[TBL] [Abstract][Full Text] [Related]
9. Use of healthy-donor granulocyte transfusions to treat infections in neutropenic patients with myeloid or lymphoid neoplasms: experience in 74 patients treated with 373 granulocyte transfusions.
Safdar A; Rodriguez G; Zuniga J; Al Akhrass F; Pande A
Acta Haematol; 2014; 131(1):50-8. PubMed ID: 24051981
[TBL] [Abstract][Full Text] [Related]
10. The value and practicality of granulocyte transfusion: a single oncology centre experience.
Al-Tanbal H; Al Humaidan H; Al-Nounou R; Roberts G; Tesfamichael K; Owaidah T
Transfus Med; 2010 Jun; 20(3):160-8. PubMed ID: 20070613
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte transfusion experience in pediatric neutropenic fever: Splitted product can be an alternative?
Oymak Y; Ayhan Y; Karapinar TH; Devrim I; Ay Y; Sarihan H; Vergin C
Transfus Apher Sci; 2015 Dec; 53(3):348-52. PubMed ID: 26227312
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte transfusion in the G-CSF era.
Price TH
Int J Hematol; 2002 Aug; 76 Suppl 2():77-80. PubMed ID: 12430904
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction.
Massey E; Paulus U; Doree C; Stanworth S
Cochrane Database Syst Rev; 2009 Jan; (1):CD005341. PubMed ID: 19160254
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.
Rutella S; Pierelli L; Sica S; Serafini R; Chiusolo P; Paladini U; Leone F; Zini G; D'Onofrio G; Leone G; Piccirillo N
Cytotherapy; 2003; 5(1):19-30. PubMed ID: 12745586
[TBL] [Abstract][Full Text] [Related]
15. Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions.
Atay D; Ozturk G; Akcay A; Yanasik M; Anak S; Devecioglu O
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e220-5. PubMed ID: 21792027
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of granulocyte transfusion in children: A single-center experience.
Kagızmanlı GA; Guzelkucuk Z; Işık P; Kara A; Ozbek NY; Yarali N
J Clin Apher; 2020 Sep; 35(5):420-426. PubMed ID: 32722895
[TBL] [Abstract][Full Text] [Related]
17. Use of G-CSF for granulocyte transfusion therapy.
Hübel K; Dale DC; Engert A; Liles WC
Cytokines Cell Mol Ther; 2000 Jun; 6(2):89-95. PubMed ID: 11108574
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte transfusions in neutropaenic children: a systematic review of the literature.
van de Wetering MD; Weggelaar N; Offringa M; Caron HN; Kuijpers TW
Eur J Cancer; 2007 Sep; 43(14):2082-92. PubMed ID: 17761413
[TBL] [Abstract][Full Text] [Related]
19. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Liang DC
Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
